0001209191-19-044045.txt : 20190801 0001209191-19-044045.hdr.sgml : 20190801 20190801165841 ACCESSION NUMBER: 0001209191-19-044045 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190610 FILED AS OF DATE: 20190801 DATE AS OF CHANGE: 20190801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernstein Karen CENTRAL INDEX KEY: 0001654055 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 19993400 MAIL ADDRESS: STREET 1: C/O VITAE PHARMACEUTICLS, INC. STREET 2: 502 WEST OFFICE CENTER DRIVE CITY: FORT WASHINGTON STATE: PA ZIP: 19034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-06-10 2019-06-10 0 0001636651 Ovid Therapeutics Inc. OVID 0001654055 Bernstein Karen C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 1 0 0 0 Stock Option (Right to Buy) 1.65 2019-06-10 4 A 0 5813 0.00 A 2029-06-09 Common Stock 5813 5813 D This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019. The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date. Danielle Mann for Karen Bernstein by POA 2019-07-31